| 000 | 03099nam a22004215i 4500 | ||
|---|---|---|---|
| 001 | 86755 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230202105343.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 161013s2016 ne | s |||| 0|eng d | ||
| 020 | _a9789402409420 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC848.H45 _bH473 2016 EB |
|
| 082 | 0 | 4 | _a616.9101 |
| 090 |
_aRC848.H45 _bH473 2016 |
||
| 245 | 1 | 0 |
_aHepatitis E Virus _cedited by Youchun Wang |
| 260 |
_aDordrecht _bSpringer Netherlands _c2016 |
||
| 300 | _a1 recurso en línea (XI, 246 p.) 35 il., 14 il. col. | ||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 1 |
_aAdvances in Experimental Medicine and Biology _x0065-2598 _v948 |
|
| 505 | 0 | _aHepatitis E virus (HEV) biology -- Characteristics and functions of HEV proteins -- Epidemiology of hepatitis E -- Hepatitis E as a zoonosis -- Genetic evolution of HEV -- Transmission of HEV -- Immunobiology and host response -- HEV cell culture systems -- HEV animal models -- Clinical manifestations of hepatitis E -- Laboratory diagnosis of HEV infection -- Treatment of HEV infection -- Prophylactic Hepatitis E vaccine. | |
| 520 | _aThis book systematically and comprehensively discusses the biological, epidemiological and clinical characteristics of the hepatitis E virus (HEV). It presents current knowledge of HEV and explores experimental methods, treatment and prevention of HEV. First identified in the 1980s and cloned in 1990, HEV is the causative agent of Hepatitis E, which mainly occurs in developing regions, such as Southeast Asia, Middle East and Africa, and significantly affects the health of the people in these areas. It is estimated that a third of the world�s population has been infected with HEV, which is transmitted via the fecal-oral route and can infect both human and animals. The book provides an overview of HEV from benchside to bedside. It is a valuable resource for researchers in the field and those in the pharmaceutical industry developing HEV vaccines, as well as physicians involved in identifying and treating those infected with the virus. | ||
| 942 |
_2lcc _cLE |
||
| 988 | 0 | 0 | _aEBOOK, EBSPRINGER |
| 650 | 7 |
_aMedicina _0comprobar BNE19900959047 _2embne _9405021 |
|
| 650 | 7 |
_aVacunas _0comprobar BNE19900984775 _2embne _9140409 |
|
| 650 | 7 |
_aVirología _0comprobar BNE19900995429 _2embne _9413113 |
|
| 700 | 1 |
_aWang, Youchun. _eeditor literario _9100699 _0Local |
|
| 830 | 0 |
_aAdvances in Experimental Medicine and Biology _x0065-2598 _v948 _9133153 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-024-0942-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9789402409420 | ||
| 907 |
_a.b12960330 _b10-10-17 _c21-11-16 |
||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gne _h0 |
||
| 945 |
_aRC848.H45 H473 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11616337 _z30-06-17 |
||
| 999 |
_c86755 _d86755 _x1 |
||